291 related articles for article (PubMed ID: 22445873)
1. Establishment of human ovarian serous carcinomas cell lines in serum free media.
Pan Z; Hooley J; Smith DH; Young P; Roberts PE; Mather JP
Methods; 2012 Mar; 56(3):432-9. PubMed ID: 22445873
[TBL] [Abstract][Full Text] [Related]
2. Isolation and establishment of human tumor stem cells.
Roberts PE
Methods Cell Biol; 2008; 86():325-42. PubMed ID: 18442655
[TBL] [Abstract][Full Text] [Related]
3. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
4. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
[TBL] [Abstract][Full Text] [Related]
6. SOX2 expression associates with stem cell state in human ovarian carcinoma.
Bareiss PM; Paczulla A; Wang H; Schairer R; Wiehr S; Kohlhofer U; Rothfuss OC; Fischer A; Perner S; Staebler A; Wallwiener D; Fend F; Fehm T; Pichler B; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Cancer Res; 2013 Sep; 73(17):5544-55. PubMed ID: 23867475
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome.
Luo L; Zeng J; Liang B; Zhao Z; Sun L; Cao D; Yang J; Shen K
Exp Mol Pathol; 2011 Oct; 91(2):596-602. PubMed ID: 21787767
[TBL] [Abstract][Full Text] [Related]
9. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer.
Abelson S; Shamai Y; Berger L; Shouval R; Skorecki K; Tzukerman M
Stem Cells; 2012 Mar; 30(3):415-24. PubMed ID: 22267284
[TBL] [Abstract][Full Text] [Related]
11. Tumor initiating cancer stem cells from human breast cancer cell lines.
Han JS; Crowe DL
Int J Oncol; 2009 May; 34(5):1449-53. PubMed ID: 19360358
[TBL] [Abstract][Full Text] [Related]
12. Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions.
Inagaki A; Soeda A; Oka N; Kitajima H; Nakagawa J; Motohashi T; Kunisada T; Iwama T
Biochem Biophys Res Commun; 2007 Sep; 361(3):586-92. PubMed ID: 17673180
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a liver metastatic model of human ovarian cancer.
Yoshida Y; Kamitani N; Sasaki H; Kusumi K; Tominaga T; Kotsuji F
Anticancer Res; 1998; 18(1A):327-31. PubMed ID: 9568098
[TBL] [Abstract][Full Text] [Related]
14. Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action.
Marsden CG; Wright MJ; Pochampally R; Rowan BG
Methods Mol Biol; 2009; 590():363-75. PubMed ID: 19763516
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines.
Felthaus O; Ettl T; Gosau M; Driemel O; Brockhoff G; Reck A; Zeitler K; Hautmann M; Reichert TE; Schmalz G; Morsczeck C
Biochem Biophys Res Commun; 2011 Apr; 407(1):28-33. PubMed ID: 21342656
[TBL] [Abstract][Full Text] [Related]
16. Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma.
Yen MJ; Hsu CY; Mao TL; Wu TC; Roden R; Wang TL; Shih IeM
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):827-31. PubMed ID: 16467095
[TBL] [Abstract][Full Text] [Related]
17. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
[TBL] [Abstract][Full Text] [Related]
18. [Isolation and identification of brain tumor stem cells from human brain neuroepithelial tumors].
Fang JS; Deng YW; Li MC; Chen FH; Wang YJ; Lu M; Fang F; Wu J; Yang ZY; Zhou XY; Wang F; Chen C
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):298-303. PubMed ID: 17456355
[TBL] [Abstract][Full Text] [Related]
19. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation.
Möbus VJ; Gerharz CD; Weikel W; Merk O; Dreher L; Kreienberg R; Moll R
Gynecol Oncol; 2001 Dec; 83(3):523-32. PubMed ID: 11733966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
